Biography & Research:
As an interdisciplinary researcher, I have identified human serum amyloid P component (hSAP) as a catalytic glycoprotein in the pathogenesis of Alzheimer’s disease (AD), through to following the cellular fate of aluminium adjuvants in clinically approved human vaccinations. The latter has allowed for the development of fluorescence-based methodologies to unequivocally identify aluminium in human brain tissue. To this end, my research focuses upon the visualisation of aluminium in human brain tissues with the overall aim of understanding its effects upon neurodegenerative and related neurological conditions, including those observed in Alzheimer's disease. Such understanding may shed light upon the shared neuropathological hallmarks that commonly link the amyloidosis disorders.